We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.53B
1-Year Est. Return 30.78%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+30.78%
3 Year Est. Return
+80.09%
5 Year Est. Return
+105.45%
10 Year Est. Return
+339.34%
AUM
$424M
AUM Growth
-$8.4M
Cap. Flow
-$9.61M
Cap. Flow %
-2.27%
Top 10 Hldgs %
42.34%
Holding
57
New
3
Increased
16
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$13M
3
SONY icon
Sony
SONY
+$12.7M
4
CRL icon
Charles River Laboratories
CRL
+$7.24M
5
AMZN icon
Amazon
AMZN
+$1.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Technology 17.07%
3 Communication Services 14.01%
4 Healthcare 11.67%
5 Financials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
1
NRG Energy
NRG
$25.1B
$21.7M 5.13%
548,669
+29,185
+6% +$1.05M
SABR icon
2
Sabre
SABR
$912M
$21.7M 5.12%
968,738
-18,055
-2% -$425K
CCK icon
3
Crown Holdings
CCK
$12.3B
$21.3M 5.04%
323,174
-36,028
-10% -$2.31M
NCLH icon
4
Norwegian Cruise Line
NCLH
$7.07B
$21.1M 4.98%
407,471
-34,766
-8% -$1.76M
CMCSA icon
5
Comcast
CMCSA
$93.4B
$19.2M 4.54%
426,877
+20,201
+5% +$895K
DGX icon
6
Quest Diagnostics
DGX
$26B
$16.5M 3.89%
+154,057
New +$15.8M
ACM icon
7
Aecom
ACM
$8.5B
$14.9M 3.51%
395,945
+31,603
+9% +$1.14M
GIL icon
8
Gildan
GIL
$9.55B
$14.5M 3.42%
408,418
-47,515
-10% -$1.79M
BHC icon
9
Bausch Health
BHC
$2.4B
$14.2M 3.36%
651,683
+62,102
+11% +$1.42M
WBS
10
DELISTED
Webster Financial
WBS
$14.2M 3.34%
301,906
-27,365
-8% -$1.29M
KMX icon
11
CarMax
KMX
$8.6B
$14.1M 3.33%
160,131
+19,431
+14% +$1.67M
NXPI icon
12
NXP Semiconductors
NXPI
$56.5B
$13.9M 3.29%
+127,563
New +$13M
CRL icon
13
Charles River Laboratories
CRL
$13.4B
$13.3M 3.14%
100,394
+54,014
+116% +$7.24M
SONY icon
14
Sony
SONY
$137B
$13.2M 3.13%
+1,120,280
New +$12.7M
MHK icon
15
Mohawk Industries
MHK
$8.79B
$13.2M 3.1%
106,016
-1,446
-1% -$186K
LKQ icon
16
LKQ Corp
LKQ
$6.3B
$13.1M 3.1%
417,607
-191,897
-31% -$5.25M
FBIN icon
17
Fortune Brands Innovations
FBIN
$5.04B
$13M 3.07%
278,252
-48,383
-15% -$2.2M
TGT icon
18
Target
TGT
$73.9B
$12.6M 2.98%
117,935
+1,467
+1% +$140K
NTRS icon
19
Northern Trust
NTRS
$33.8B
$12.4M 2.93%
133,027
-5,075
-4% -$466K
QRVO icon
20
Qorvo
QRVO
$9.18B
$11.9M 2.8%
160,107
-40,967
-20% -$2.98M
SIVB
21
DELISTED
SVB Financial Group
SIVB
$11.6M 2.75%
55,720
+1,107
+2% +$232K
WUBA
22
DELISTED
58.com Inc
WUBA
$10.5M 2.48%
212,951
+28,003
+15% +$1.55M
FWONK icon
23
Liberty Media Series C
FWONK
$23.8B
$10.3M 2.43%
255,521
-29,602
-10% -$1.15M
TTWO icon
24
Take-Two Interactive
TTWO
$39.9B
$9.6M 2.27%
76,574
-53,370
-41% -$6.66M
CCL icon
25
Carnival Corporation Ltd
CCL
$31.8B
$8.36M 1.97%
191,333
+13,475
+8% +$622K

Similar funds

M.D. Sass LLC's Q3 2019 Portfolio in Review

As of Q3 2019, M.D. Sass LLC held 57 positions worth $424M, down 1.9% from $432M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

M.D. Sass LLC's Q3 2019 filing shows 3 new, 16 increased, 32 reduced and 4 closed positions. Its largest new stake was Quest Diagnostics: 154,057 shares worth $16.5M. The largest sale was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.

  • M.D. Sass LLC's largest Q3 2019 buy was Quest Diagnostics: 154,057 shares worth $16.5M.
  • M.D. Sass LLC added most to Charles River Laboratories in Q3 2019, an estimated $7.24M increase.
  • M.D. Sass LLC's biggest Q3 2019 reduction was Vulcan Materials, cutting an estimated $10.4M.
  • M.D. Sass LLC fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q3 2019, selling an estimated $14.5M.
  • M.D. Sass LLC's ten largest holdings make up 42% of its $424M portfolio in Q3 2019.
  • M.D. Sass LLC opened 3 new positions and closed 4 in Q3 2019.
  • M.D. Sass LLC's portfolio value fell 1.9% quarter-over-quarter to $424M.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.